As of 2026-03-20, the Relative Valuation of Cardiol Therapeutics Inc (CRDL.TO) is (3.30) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.45 CAD, the upside of Cardiol Therapeutics Inc based on Relative Valuation is -327.6%.
The range of the Relative Valuation is (2.64) - (3.75) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.5x - 12.0x | 10.6x |
| Forward P/E multiples | 8.5x - 12.2x | 10.6x |
| Fair Price | (2.64) - (3.75) | (3.30) |
| Upside | -282.1% - -358.5% | -327.6% |
| Date | P/E |
| 2026-03-17 | -4.66 |
| 2026-03-16 | -4.69 |
| 2026-03-13 | -4.53 |
| 2026-03-12 | -4.59 |
| 2026-03-11 | -4.72 |
| 2026-03-10 | -4.59 |
| 2026-03-09 | -4.27 |
| 2026-03-06 | -4.18 |
| 2026-03-05 | -4.37 |
| 2026-03-04 | -4.50 |
| 2026-03-03 | -4.43 |
| 2026-03-02 | -4.53 |
| 2026-02-27 | -4.43 |
| 2026-02-26 | -4.66 |
| 2026-02-25 | -4.47 |
| 2026-02-24 | -4.40 |
| 2026-02-23 | -4.34 |
| 2026-02-20 | -4.47 |
| 2026-02-19 | -4.50 |
| 2026-02-18 | -4.66 |
| 2026-02-17 | -4.53 |
| 2026-02-13 | -4.50 |
| 2026-02-12 | -4.47 |
| 2026-02-11 | -4.66 |
| 2026-02-10 | -4.66 |
| 2026-02-09 | -4.59 |
| 2026-02-06 | -4.40 |
| 2026-02-05 | -4.21 |
| 2026-02-04 | -4.53 |
| 2026-02-03 | -4.47 |
| 2026-02-02 | -4.21 |
| 2026-01-30 | -4.11 |
| 2026-01-29 | -4.21 |
| 2026-01-28 | -4.27 |
| 2026-01-27 | -4.37 |
| 2026-01-26 | -4.40 |
| 2026-01-23 | -4.56 |
| 2026-01-22 | -4.53 |
| 2026-01-21 | -4.53 |
| 2026-01-20 | -4.53 |
| 2026-01-19 | -4.85 |
| 2026-01-16 | -4.75 |
| 2026-01-15 | -4.30 |
| 2026-01-14 | -4.40 |
| 2026-01-13 | -4.34 |
| 2026-01-12 | -4.34 |
| 2026-01-09 | -4.48 |
| 2026-01-08 | -4.50 |
| 2026-01-07 | -4.53 |
| 2026-01-06 | -4.47 |